Advanced Filters
noise

depression Clinical Trials

A listing of depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,264 clinical trials
M Molly F Davis, PhD

Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)

This pilot randomized controlled trial will examine the feasibility, acceptability and preliminary efficacy of an adolescent depression prevention program, Brief Interpersonal Psychotherapy-Adolescent Skills Training (B-IPT-AST), in primary care.

13 - 17 years of age All Phase N/A
A Adam W Carrico, PhD

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

The purpose of this randomized controlled trial is to understand how a cognitive-behavioral treatment (a form of psychological treatment) for depression changes the gut microbiome (micro-organisms that regulate the health of the gut), immune system, and the brain functioning in people living with HIV.

18 years of age All Phase N/A
J Jennifer Felger, PhD

Dopaminergic Therapy for Anhedonia - 2

The purpose of this 8-week, double-blind, placebo-controlled, study is to explore new treatment options for people with depression who have high inflammation and anhedonia. Seventy male and female participants with depression, between 25-55 years of age, with higher levels of inflammation and anhedonia will be randomized to receive L-DOPA or …

25 - 55 years of age All Phase 4
A Andrew H Miller, MD

Inflammation and Depression in People With HIV

The purpose of this 10-week, double-blind, placebo-controlled study is to determine whether inflammation impacts reward and motor neural circuitry to contribute to depressive symptoms like anhedonia and psychomotor slowing in people with Human Immunodeficiency Virus (HIV) and depression. Sixty male and female patients with HIV who have depression, anhedonia and …

18 - 65 years of age All Phase 2
J Johan Lindqvist, MD, PhD

Long-term Efficacy of Pramipexole in Anhedonic Depression

The purpose of the study is to assess the long-term efficacy and safety of add-on pramipexole for treatment of patients with anhedonic depression.

18 - 75 years of age All Phase 3
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD

Background People with TRD are often helped by electroconvulsive therapy (ECT). But ECT can affect memory and thinking. Researchers want to study a treatment called TEST that uses less electricity. Objective To study the safety and feasibility of TEST and assess its antidepressant effects. Eligibility Adults aged 25-64 with major …

25 - 64 years of age All Phase N/A
J Jessica DALAUDIERE

Inflammation and Blood Brain Barrier Integrity as Biomarkers of Suicidal Behavior

Recent studies have revealed an association between history of suicide attempt and inflammatory markers in both the cerebrospinal fluid and the plasma. Post mortem studies have shown an increase in microglial activation in the brain tissue of suicide victims. However the relationship between peripheral and central inflammation in suicide is …

18 - 55 years of age All Phase N/A
L Lisa A Brenner, PhD

Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression

This study plans to learn more about the use of one of two self-guided online cognitive behavioral therapy courses. One is focused on symptoms of depression and one is focused on history of suicidal thoughts and behaviors.

18 - 65 years of age All Phase 2
P Pascal Frilloux, Dr

Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects

Depression is one of the most common mental disorders, affecting nearly 10% of men and 20% of women worldwide. It is associated with a significant increase in mortality, mainly due to suicidal behavior. The Diagnostic and Statistical Manual of Mental Disorders (DSM) defines a Major Depressive Episode (MDE) by a …

18 - 65 years of age All Phase N/A
S Stefan Klöppel, Prof. Dr. med.

The Brain-Heart-Gut Connection

Major Depressive Disorder (MDD) often co-occurs with cardiovascular and gastrointestinal symptoms, highlighting the importance of the brain-heart-gut connection in developing comprehensive treatments. Previous research suggests that key hubs in the depression network, such as the dorsolateral prefrontal cortex (DLPFC) and the subgenual anterior cingulate cortex (sgACC), overlap with structures that …

18 - 65 years of age All Phase N/A

Simplify language using AI